scholarly journals The impact of the variation in death certification and coding practices on trends in mortality from ischaemic heart disease

2002 ◽  
Vol 25 (4) ◽  
pp. 189 ◽  
Author(s):  
Linping Chen ◽  
Sue Walker ◽  
Shilu Tong
Keyword(s):  
Heart Disease ◽  
Ischaemic Heart Disease ◽  
Death Certificates ◽  
Death Certification ◽  
Mortality Trends ◽  
Factors Affecting ◽  
Icd Codes ◽  
The Impact

This review examines the literature relating to the effect of death certification practices, coding and the terminology used by certifiers on trends in mortality from ischaemic heart disease (IHD). The review identifies factors that affect mortality trends in a number of countries and discusses methods for assessing the impact of these issues on trends in mortality from IHD. The review found that although the magnitude of the effects of the issues on trends in mortality from ischaemic heart disease varied among countries and sub-populations, miscertification and the resultant assignment of misleading ICD codes, particularly for ill-defined cardiovascular conditions, were important factors affecting the IHD mortality trends. In light of these findings, it is essential to monitor regularly the accuracy of death certificates for IHD and consider necessary adjustments in analysing mortality trends from IHD.

scholarly journals P47 The impact of comorbid ischaemic heart disease on exercise capacity in COPD patients

Thorax ◽  
2011 ◽  
Vol 66 (Suppl 4) ◽  
pp. A87-A87
Author(s):  
A. R. C. Patel ◽  
A. D. Alahmari ◽  
G. C. Donaldson ◽  
B. Kowlessar ◽  
A. J. Mackay ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischaemic Heart Disease ◽  
Exercise Capacity ◽  
Copd Patients ◽  
The Impact

scholarly journals Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational study

BMJ Open ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. e027199
Author(s):  
Tomas Jernberg ◽  
Daniel Lindholm ◽  
Lars Pål Hasvold ◽  
Bodil Svennblad ◽  
Johan Bodegård ◽  
...  
Keyword(s):  
Heart Disease ◽  
Relative Risk ◽  
Ischaemic Heart Disease ◽  
Lower Risk ◽  
Older Patients ◽  
Cox Model ◽  
Younger Patients ◽  
Linear Association ◽  
The Impact ◽  
First Time

ObjectivesTo compare short-term cardiovascular (CV) outcome in type 2 diabetes (T2D) patients without ischaemic heart disease (IHD), with IHD but no prior myocardial infarction (MI), and those with prior MI; and assess the impact on risk of age when initiating first-time glucose-lowering drug (GLD).DesignCohort study linking morbidity, mortality and medication data from Swedish national registries.ParticipantsFirst-time users of GLD during 2007–2016.OutcomesPredicted cumulative incidence for the CV outcome (MI, stroke and CV mortality) was estimated. A Cox model was developed where age at GLD start and CV risk was modelled.Results260 070 first-time GLD users were included, 221 226 (85%) had no IHD, 16 294 (6%) had stable IHD—prior MI and 22 550 (9%) had IHD+MI. T2D patients without IHD had a lower risk of CV outcome compared with the IHD populations (±prior MI), (3-year incidence 4.78% vs 5.85% and 8.04%). The difference in CV outcome was primarily driven by a relative greater MI risk among the IHD patients. For T2D patients without IHD, an almost linear association between age at start of GLD and relative risk was observed, whereas in IHD patients, the younger (<60 years) patients had a relative greater risk compared with older patients.ConclusionsT2D patients without IHD had a lower risk of the CV outcome compared with the T2D populations with IHD, primarily driven by a greater risk of MI. For T2D patients without IHD, an almost linear association between age at start of GLD and relative risk was observed, whereas in IHD patients, the younger patients had a relative greater risk compared with older patients. Our findings suggest that intense risk prevention should be the key strategy in the management of T2D patients, especially for younger patients.

scholarly journals Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK

Heart ◽  
2020 ◽  
Vol 106 (11) ◽  
pp. 810-816 ◽  
Author(s):  
Francesca Crowe ◽  
Dawit T Zemedikun ◽  
Kelvin Okoth ◽  
Nicola Jaime Adderley ◽  
Gavin Rudge ◽  
...  
Keyword(s):  
Heart Disease ◽  
Latent Class Analysis ◽  
Ischaemic Heart Disease ◽  
Latent Class ◽  
Health Improvement ◽  
Class Analysis ◽  
Musculoskeletal Conditions ◽  
Risk Of Mortality ◽  
The Uk ◽  
The Impact

ObjectivesThe objective of this study is to use latent class analysis of up to 20 comorbidities in patients with a diagnosis of ischaemic heart disease (IHD) to identify clusters of comorbidities and to examine the associations between these clusters and mortality.MethodsLongitudinal analysis of electronic health records in the health improvement network (THIN), a UK primary care database including 92 186 men and women aged ≥18 years with IHD and a median of 2 (IQR 1–3) comorbidities.ResultsLatent class analysis revealed five clusters with half categorised as a low-burden comorbidity group. After a median follow-up of 3.2 (IQR 1.4–5.8) years, 17 645 patients died. Compared with the low-burden comorbidity group, two groups of patients with a high-burden of comorbidities had the highest adjusted HR for mortality: those with vascular and musculoskeletal conditions, HR 2.38 (95% CI 2.28 to 2.49) and those with respiratory and musculoskeletal conditions, HR 2.62 (95% CI 2.45 to 2.79). Hazards of mortality in two other groups of patients characterised by cardiometabolic and mental health comorbidities were also higher than the low-burden comorbidity group; HR 1.46 (95% CI 1.39 to 1.52) and 1.55 (95% CI 1.46 to 1.64), respectively.ConclusionsThis analysis has identified five distinct comorbidity clusters in patients with IHD that were differentially associated with risk of mortality. These analyses should be replicated in other large datasets, and this may help shape the development of future interventions or health services that take into account the impact of these comorbidity clusters.

Diagnosis and assessment of stroke

2016 ◽  
Author(s):  
Candice Delcourt ◽  
Craig Anderson
Keyword(s):  
Heart Disease ◽  
Ischaemic Stroke ◽  
Ischaemic Heart Disease ◽  
Cause Of Death ◽  
Physical Disability ◽  
Early Phase ◽  
Haemorrhagic Stroke ◽  
Common Cause ◽  
The World ◽  
The Impact

Approximately 20 million strokes occur in the world each year and over one-quarter of these are fatal. This makes stroke the second most common cause of death, after ischaemic heart disease, and strokes are responsible for 6 million deaths (almost 10% of all deaths) annually. Stroke has major consequences in terms of residual physical disability, depression, dementia, epilepsy, and carer burden. Moreover, around 20% of survivors experience a further stroke or serious vascular event within a few years of the index event. Ischaemic stroke contributes the greatest share of the impact of stroke, with a rate of approximately 1 in 1000 person-years and accounting for between 60% (in Asia) and 90% (in Western ‘white’ populations) of all strokes around the world. Diagnosis and assessment are essentially clinical and confirmed by CT or MRI scanning. Prognostication is difficult in the early phase of haemorrhagic stroke and in ischaemic stroke is affected by the availability and timely use of treatments to recanalize the occluded vessel.

Sign in / Sign up

Export Citation Format

Share Document